GB201208548D0 - Compound and method - Google Patents

Compound and method

Info

Publication number
GB201208548D0
GB201208548D0 GBGB1208548.6A GB201208548A GB201208548D0 GB 201208548 D0 GB201208548 D0 GB 201208548D0 GB 201208548 A GB201208548 A GB 201208548A GB 201208548 D0 GB201208548 D0 GB 201208548D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1208548.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PCI Biotech AS
Original Assignee
PCI Biotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PCI Biotech AS filed Critical PCI Biotech AS
Priority to GBGB1208548.6A priority Critical patent/GB201208548D0/en
Publication of GB201208548D0 publication Critical patent/GB201208548D0/en
Priority to PL13725109T priority patent/PL2849791T3/pl
Priority to HK15104699.9A priority patent/HK1203850B/en
Priority to KR1020147035218A priority patent/KR20150013803A/ko
Priority to EP13725109.6A priority patent/EP2849791B1/en
Priority to CA2873259A priority patent/CA2873259C/en
Priority to HUE13725109A priority patent/HUE039725T2/hu
Priority to RU2014150569A priority patent/RU2675830C2/ru
Priority to IN9418DEN2014 priority patent/IN2014DN09418A/en
Priority to SG11201407603YA priority patent/SG11201407603YA/en
Priority to CN201380037602.8A priority patent/CN104780941B/zh
Priority to KR1020207019532A priority patent/KR102269861B1/ko
Priority to BR112014028315-0A priority patent/BR112014028315B1/pt
Priority to US14/401,215 priority patent/US9901636B2/en
Priority to MX2014013516A priority patent/MX362237B/es
Priority to HRP20181276TT priority patent/HRP20181276T1/hr
Priority to ES13725109.6T priority patent/ES2682762T3/es
Priority to DK13725109.6T priority patent/DK2849791T3/en
Priority to SI201331125T priority patent/SI2849791T1/sl
Priority to PCT/EP2013/059968 priority patent/WO2013189663A1/en
Priority to JP2015512042A priority patent/JP6456284B2/ja
Priority to AU2013279748A priority patent/AU2013279748B2/en
Priority to PT13725109T priority patent/PT2849791T/pt
Priority to NZ630582A priority patent/NZ630582A/en
Priority to ZA2014/08406A priority patent/ZA201408406B/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB1208548.6A 2012-05-15 2012-05-15 Compound and method Ceased GB201208548D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB1208548.6A GB201208548D0 (en) 2012-05-15 2012-05-15 Compound and method
NZ630582A NZ630582A (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
BR112014028315-0A BR112014028315B1 (pt) 2012-05-15 2013-05-14 Composto, métodos in vitro ou ex vivo para introdução de uma molécula dentro do citosol de uma célula, para obter a morte de uma célula e para expressar uma molécula antigênica ou uma parte da mesma na superfície de uma célula, composição farmacêutica, usos de um composto ou de uma composição e de uma célula ou população de células, e, kit
MX2014013516A MX362237B (es) 2012-05-15 2013-05-14 Conjugado de un fotosensibilizador y quitosan y usos de los mismos.
KR1020147035218A KR20150013803A (ko) 2012-05-15 2013-05-14 광감제 및 키토산의 컨쥬게이트, 및 이의 용도
EP13725109.6A EP2849791B1 (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
CA2873259A CA2873259C (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
HUE13725109A HUE039725T2 (hu) 2012-05-15 2013-05-14 Fotoszenzitizáló és kitozán konjugátum és alkalmazásaik
RU2014150569A RU2675830C2 (ru) 2012-05-15 2013-05-14 Конъюгат фотосенсибилизатора и хитозана и его применение
IN9418DEN2014 IN2014DN09418A (enExample) 2012-05-15 2013-05-14
SG11201407603YA SG11201407603YA (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
CN201380037602.8A CN104780941B (zh) 2012-05-15 2013-05-14 光敏剂与壳聚糖的缀合物及其用途
KR1020207019532A KR102269861B1 (ko) 2012-05-15 2013-05-14 광감제 및 키토산의 컨쥬게이트, 및 이의 용도
PL13725109T PL2849791T3 (pl) 2012-05-15 2013-05-14 Koniugat środka fotouczulającego i chitozanu i jego zastosowania
US14/401,215 US9901636B2 (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
HK15104699.9A HK1203850B (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
HRP20181276TT HRP20181276T1 (hr) 2012-05-15 2013-05-14 Konjugat fotosenzibilizatora s hitozanom i njegova upotreba
ES13725109.6T ES2682762T3 (es) 2012-05-15 2013-05-14 Conjugado de un fotosensibilizador y quitosano y usos del mismo
DK13725109.6T DK2849791T3 (en) 2012-05-15 2013-05-14 CONJUGATE OF A PHOTOSENSITIZER AND CHITOSAN AND APPLICATIONS THEREOF
SI201331125T SI2849791T1 (sl) 2012-05-15 2013-05-14 Konjugat fotosenzitizatorja in hitozan ter njihove uporabe
PCT/EP2013/059968 WO2013189663A1 (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
JP2015512042A JP6456284B2 (ja) 2012-05-15 2013-05-14 光増感物質とキトサンのコンジュゲートおよびその使用
AU2013279748A AU2013279748B2 (en) 2012-05-15 2013-05-14 Conjugate of a photosensitiser and chitosan and uses thereof
PT13725109T PT2849791T (pt) 2012-05-15 2013-05-14 Conjugado de um fotosensibilizante e de quitosano e suas utilizações
ZA2014/08406A ZA201408406B (en) 2012-05-15 2014-11-17 Conjugate of a photosensitiser and chitosan and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1208548.6A GB201208548D0 (en) 2012-05-15 2012-05-15 Compound and method

Publications (1)

Publication Number Publication Date
GB201208548D0 true GB201208548D0 (en) 2012-06-27

Family

ID=46458880

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1208548.6A Ceased GB201208548D0 (en) 2012-05-15 2012-05-15 Compound and method

Country Status (23)

Country Link
US (1) US9901636B2 (enExample)
EP (1) EP2849791B1 (enExample)
JP (1) JP6456284B2 (enExample)
KR (2) KR20150013803A (enExample)
CN (1) CN104780941B (enExample)
AU (1) AU2013279748B2 (enExample)
BR (1) BR112014028315B1 (enExample)
CA (1) CA2873259C (enExample)
DK (1) DK2849791T3 (enExample)
ES (1) ES2682762T3 (enExample)
GB (1) GB201208548D0 (enExample)
HR (1) HRP20181276T1 (enExample)
HU (1) HUE039725T2 (enExample)
IN (1) IN2014DN09418A (enExample)
MX (1) MX362237B (enExample)
NZ (1) NZ630582A (enExample)
PL (1) PL2849791T3 (enExample)
PT (1) PT2849791T (enExample)
RU (1) RU2675830C2 (enExample)
SG (1) SG11201407603YA (enExample)
SI (1) SI2849791T1 (enExample)
WO (1) WO2013189663A1 (enExample)
ZA (1) ZA201408406B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
AU2014390262B2 (en) 2014-04-11 2020-11-26 Pci Biotech As Method of treating melanoma
KR102678732B1 (ko) * 2014-08-28 2024-06-25 피씨아이 바이오테크 에이에스 화합물 및 방법
CN104650259A (zh) * 2015-01-23 2015-05-27 广西大学 一种纳米孔壳聚糖四(4-磺酸基苯基)金属卟啉微球及其制备方法和使用方法
GB201503776D0 (en) 2015-03-05 2015-04-22 Pci Biotech As Compound and method
GB201511159D0 (en) 2015-06-24 2015-08-05 Univ Nottingham Controlled cell delivery vehicle and treatment of tumours
EP3433422B1 (en) * 2016-03-22 2020-11-18 Åbo Akademi University Polysaccharide derivatives as optical brightening agents
KR20190013289A (ko) * 2017-08-01 2019-02-11 순천대학교 산학협력단 수용성 키토산을 포함하는 나노광증감제
GB201801169D0 (en) 2018-01-24 2018-03-07 Pci Biotech As Method
CN108892743A (zh) * 2018-05-28 2018-11-27 南京工业大学 用于光动力抗菌的纳米光敏剂,其制备方法及应用
GB202101726D0 (en) 2021-02-08 2021-03-24 Pci Biotech As Method
CN115399328B (zh) * 2021-05-27 2024-03-22 中国科学院化学研究所 一种多糖基杀菌材料及其制备方法和应用
GB202115451D0 (en) 2021-10-27 2021-12-08 Pci Biotech As Method
CN117285662A (zh) * 2022-06-15 2023-12-26 南京仁为医药科技有限公司 一种壳聚糖双吡啶季铵盐及其制备方法
GB202301312D0 (en) 2023-01-30 2023-03-15 Pci Biotech As Method and product

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
US20020022032A1 (en) 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
JP2002241307A (ja) * 2001-02-19 2002-08-28 Yasuhiko Tabata 光増感剤を含有する超音波治療用活性酸素発生剤
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
GB0415663D0 (en) * 2004-07-13 2004-08-18 Psimei Pharmaceuticals Plc Compound
EP1888115A2 (en) 2005-05-16 2008-02-20 Universite De Geneve Compounds for photochemotherapy
JP4287411B2 (ja) * 2005-07-01 2009-07-01 株式会社東芝 仮想メモリシステムおよび仮想記憶方法
CN101024087A (zh) * 2007-03-28 2007-08-29 长沙理工大学 壳聚糖-多肽-卟啉纳米药物载体及其制备和应用
KR101035269B1 (ko) 2007-04-23 2011-05-26 한국과학기술연구원 고분자 유도체-광감작제 복합체를 이용한 새로운 광역학치료제
KR20090047872A (ko) 2007-11-08 2009-05-13 인제대학교 산학협력단 신규 카보하이드레이트 복합 클로린 화합물 및 이의제조방법
WO2009077908A1 (en) 2007-12-14 2009-06-25 University Of Lausanne Colloidal particle comprising multivalent cyclic anions
KR101076717B1 (ko) 2008-11-07 2011-10-26 재단법인대구경북과학기술원 광역학 치료용 나노구조체 및 그 제조방법
US20100129432A1 (en) 2008-11-25 2010-05-27 Taipei Medical University Microorganism-killing combination
KR100918811B1 (ko) 2009-04-29 2009-09-25 다이아텍코리아 주식회사 클로린 e6-엽산 결합 화합물 및 키토산을 함유하는 암 치료용 약학적 조성물
CN101977608A (zh) 2009-04-29 2011-02-16 多异亚德韩国株式会社 含有二氢卟酚e6-叶酸共轭化合物和壳聚糖的用于癌症治疗的药物组合物
US20120184495A1 (en) * 2009-06-12 2012-07-19 Amrita Vishwa Vidyapeetham University Kerala Targeted nano-photomedicines for photodynamic therapy of cancer
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
KR101228106B1 (ko) 2010-01-21 2013-02-01 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
KR101250150B1 (ko) 2010-10-29 2013-04-04 가톨릭대학교 산학협력단 광역학치료를 위한 고분자-광응답제 접합체 및 이의 제조방법

Also Published As

Publication number Publication date
RU2675830C2 (ru) 2018-12-25
CN104780941A (zh) 2015-07-15
BR112014028315B1 (pt) 2022-02-22
HUE039725T2 (hu) 2019-01-28
MX362237B (es) 2019-01-09
ZA201408406B (en) 2016-02-24
PT2849791T (pt) 2018-10-04
CA2873259C (en) 2021-08-03
KR20200085380A (ko) 2020-07-14
JP6456284B2 (ja) 2019-01-23
EP2849791B1 (en) 2018-07-04
AU2013279748A1 (en) 2014-11-20
JP2015516496A (ja) 2015-06-11
RU2014150569A (ru) 2016-07-10
ES2682762T3 (es) 2018-09-21
US9901636B2 (en) 2018-02-27
EP2849791A1 (en) 2015-03-25
US20150202293A1 (en) 2015-07-23
KR102269861B1 (ko) 2021-06-28
PL2849791T3 (pl) 2019-03-29
BR112014028315A2 (pt) 2017-10-24
SG11201407603YA (en) 2014-12-30
MX2014013516A (es) 2015-11-13
NZ630582A (en) 2017-02-24
AU2013279748B2 (en) 2018-08-02
HK1203850A1 (en) 2015-11-06
CA2873259A1 (en) 2013-12-27
DK2849791T3 (en) 2018-08-13
KR20150013803A (ko) 2015-02-05
CN104780941B (zh) 2019-01-15
HRP20181276T1 (hr) 2018-11-16
IN2014DN09418A (enExample) 2015-07-17
WO2013189663A1 (en) 2013-12-27
SI2849791T1 (sl) 2018-10-30

Similar Documents

Publication Publication Date Title
GB2500915B (en) Arrangement and method
GB201223172D0 (en) Method
GB201208548D0 (en) Compound and method
GB201212937D0 (en) Method
GB201212932D0 (en) Method
PL2817775T3 (pl) Sposób pomiaru oglądalności
GB201212934D0 (en) Method
GB201213636D0 (en) Method
GB201210858D0 (en) Method
SG11201407032WA (en) Method
GB201218570D0 (en) Method
GB201202198D0 (en) Method
IL236154A0 (en) compound and method
SG11201500474PA (en) Nutriculture member and nutriculture method
GB201223316D0 (en) Method
GB201222820D0 (en) Woolscouring method and composition
GB201211393D0 (en) Method
GB201222737D0 (en) Method
GB201217688D0 (en) Method
GB201214029D0 (en) method
GB201210147D0 (en) Method
GB201201332D0 (en) Method
GB201206859D0 (en) Method and composition
ZA201500172B (en) Plant-disease-control composition and plant-disease-control method
GB201213858D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)